...Netherlands Business: Infectious Date completed: 4/15/14 Type: Venture financing Raised: €5 million ($6.9 million) Investors: Changchun BCHT...

...is comprised of BLP-based Mimopath technology carrying trimeric fusion proteins and is in preclinical testing. Changchun BCHT Biotechnology Co....

...free-of-charge or at low cost (see BioCentury, July 19, 2010). BioDiem Ltd. (ASX:BDM), Melbourne, Australia Changchun BCHT Biotechnology Co....